We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+7.4%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$9.77B
AUM Growth
+$1.3B
Cap. Flow
+$764M
Cap. Flow %
7.83%
Top 10 Hldgs %
16.04%
Holding
2,679
New
514
Increased
162
Reduced
972
Closed
72

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$107M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$98.5M
3
DD icon
DuPont de Nemours
DD
+$45.6M
4
EPD icon
Enterprise Products Partners
EPD
+$37.3M
5
MDT icon
Medtronic
MDT
+$36.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$23.3M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$9.08M
3
WGL
Wgl Holdings
WGL
+$4.93M
4
DCT
DCT Industrial Trust Inc.
DCT
+$3.95M
5
WCG
Wellcare Health Plans, Inc.
WCG
+$3.86M

Sector Composition

Rank Sector Weight
1 Technology 16.73%
2 Financials 15.03%
3 Healthcare 13.46%
4 Industrials 10.27%
5 Consumer Discretionary 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PETQ
2051
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$210K ﹤0.01%
+5,349
New +$178K
FRO icon
2052
Frontline
FRO
$9.09B
$210K ﹤0.01%
+36,108
New +$191K
TPIC
2053
DELISTED
TPI Composites
TPIC
$209K ﹤0.01%
7,332
– –
CNXN icon
2054
PC Connection
CNXN
$2.04B
$209K ﹤0.01%
5,366
– –
VRTV
2055
DELISTED
VERITIV CORPORATION
VRTV
$208K ﹤0.01%
5,727
– –
ZAGG
2056
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$208K ﹤0.01%
14,118
– –
CRVL icon
2057
CorVel
CRVL
$3.17B
$207K ﹤0.01%
10,305
-5,670
-35% -$109K
COLL icon
2058
Collegium Pharmaceutical
COLL
$917M
$207K ﹤0.01%
+14,032
New +$249K
BRS
2059
DELISTED
Bristow Group, Inc.
BRS
$207K ﹤0.01%
17,044
– –
SGYP
2060
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$206K ﹤0.01%
121,416
+1,570
+1% +$2.81K
TCRT icon
2061
Alaunos Therapeutics
TCRT
$4.86M
$206K ﹤0.01%
429
-11
-3% -$4.72K
PKE icon
2062
Park Aerospace
PKE
$806M
$206K ﹤0.01%
10,569
– –
FMNB icon
2063
Farmers National Banc Corp
FMNB
$967M
$205K ﹤0.01%
13,414
– –
NERV icon
2064
Minerva Neurosciences
NERV
$188M
$205K ﹤0.01%
2,038
– –
YORW icon
2065
York Water
YORW
$535M
$204K ﹤0.01%
6,695
– –
OXFD
2066
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$203K ﹤0.01%
+12,520
New +$179K
SMHI icon
2067
SEACOR Marine Holdings
SMHI
$263M
$203K ﹤0.01%
8,966
– –
FISI icon
2068
Financial Institutions
FISI
$828M
$203K ﹤0.01%
6,461
– –
GDEN
2069
DELISTED
Golden Entertainment
GDEN
$202K ﹤0.01%
8,432
– –
PGNX
2070
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$202K ﹤0.01%
32,263
– –
KEYW
2071
DELISTED
The KEYW Holding Corporation
KEYW
$202K ﹤0.01%
23,342
– –
NSTG
2072
DELISTED
NanoString Technologies, Inc.
NSTG
$202K ﹤0.01%
11,330
– –
INO icon
2073
Inovio Pharmaceuticals
INO
$92.3M
$202K ﹤0.01%
3,025
– –
LFCR icon
2074
Lifecore Biomedical
LFCR
$181M
$202K ﹤0.01%
14,010
– –
SENS icon
2075
Senseonics Holdings Inc
SENS
$412M
$202K ﹤0.01%
2,114
+395
+23% +$32.3K
81 82
83
84 85

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

MetLife Investment Management's Q3 2018 Portfolio in Review

As of Q3 2018, MetLife Investment Management held 2,679 positions worth $9.77B, up 15% from $8.47B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

MetLife Investment Management deployed $764M of net new capital in Q3 2018, opening 514 new positions and adding to 162 existing holdings. Its largest new stake was Alphabet (Google) Class C: 1,791,300 shares worth $107M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $23.3M trimmed.

  • MetLife Investment Management's largest Q3 2018 buy was Alphabet (Google) Class C: 1,791,300 shares worth $107M.
  • MetLife Investment Management added most to iShares Core US Aggregate Bond ETF in Q3 2018, an estimated $98.5M increase.
  • MetLife Investment Management's biggest Q3 2018 reduction was Apple, cutting an estimated $23.3M.
  • MetLife Investment Management fully exited Wgl Holdings in Q3 2018, selling an estimated $4.93M.
  • MetLife Investment Management's ten largest holdings make up 16% of its $9.77B portfolio in Q3 2018.
  • MetLife Investment Management opened 514 new positions and closed 72 in Q3 2018.
  • MetLife Investment Management's portfolio value rose 15% quarter-over-quarter to $9.77B.

Based on MetLife Investment Management's 13F filing for Q3 2018, filed 14 Nov 2018.